Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.

Autor: Wüsthoff LEC; Unit for Clinical Research on Addictions, Oslo University Hospital, PO Box 4959 Nydalen, Oslo, 0424, Norway. linwus@ous-hf.no.; Norwegian Centre for Addiction Reasearch, Institute of Clinical Medicine, University of Oslo, PO Box 1039 Blindern, Oslo, 0315, Norway. linwus@ous-hf.no., Lund-Johansen F; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Gaustadalleen 21, Oslo, 0349, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318, Oslo, Norway., Henriksen K; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway.; Student Health Services, Student Welfare Services in Oslo, Problemveien 9, Oslo, 0313, Norway., Wildendahl G; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Jacobsen JA; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Gomes L; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Anjum HS; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Barlinn R; Department of Microbiology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway., Kran AB; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222 Skøyen, Oslo, 0213, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; KG Jebsen Centre for B cell Malignancies, and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 4950 Nydalen, Oslo, 0424, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.

Publikováno v: Harm reduction journal [Harm Reduct J] 2024 Jun 19; Vol. 21 (1), pp. 120. Date of Electronic Publication: 2024 Jun 19.

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study.

Autor: Malme KB; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: krimal@ahus.no., Ulstein K; Agency for Social and Welfare Services, City of Oslo, Norway., Finbråten AK; Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway., Wüsthoff LEC; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway; Unit for Clinical Research on Addictions, Oslo University Hospital Health Trust, Oslo, Norway., Kielland KB; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumundal, Norway., Hauge J; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumundal, Norway., Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Norway., Midgard H; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2023 Jun; Vol. 116, pp. 104044. Date of Electronic Publication: 2023 May 05.